Physician profile
Bernardo Cortese
NPI 1457180382
$45,368.60
in general payments reported to CMS, 2019-2025
9 companies · $44K in 2025
The $44K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,369 · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $5,142 · Travel and Lodging: $3,925 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,726.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $5,141.50 |
| Travel and Lodging | $3,925.33 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,575.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13,451.34 | 2024-2025 | General - Vascular Access, General - Therapies, Avvigo Guidance System |
| Angiodynamics, INC. | $10,111.18 | 2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Shockwave Medical, INC | $9,487.26 | 2025 | |
| Abbott Laboratories | $7,954.72 | 2024-2025 | Diamondback Coronary, Dragonfly Opstar, Optis |
| Gentuity, LLC | $3,128.79 | 2025 | Gentuity Hf-Oct Imaging System, Vis-Rx Prime, Vis-Rx |
| Abiomed | $607.93 | 2024-2025 | Impella |
| Medtronic, INC. | $325.61 | 2024-2025 | Corevalve Evolut R, Symplicity G3 |
| Becton, Dickinson and Company | $301.77 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernardo Cortese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.